Results 41 to 50 of about 662,630 (312)

Morphoproteomic profiling of the mammalian target of rapamycin (mTOR) signaling pathway in desmoplastic small round cell tumor (EWS/WT1), Ewing's sarcoma (EWS/FLI1) and Wilms' tumor(WT1). [PDF]

open access: yes, 2013
BackgroundDesmoplastic small round cell tumor (DSRCT) is a rare sarcoma in adolescents and young adults. The hallmark of this disease is a EWS-WT1 translocation resulting from apposition of the Ewing's sarcoma (EWS) gene with the Wilms' tumor (WT1) gene.
Anderson, Pete M   +6 more
core   +2 more sources

The Epidemiology of Sarcoma [PDF]

open access: yesClinical Sarcoma Research, 2012
AbstractSarcomas account for over 20% of all pediatric solid malignant cancers and less than 1% of all adult solid malignant cancers. The vast majority of diagnosed sarcomas will be soft tissue sarcomas, while malignant bone tumors make up just over 10% of sarcomas. The risks for sarcoma are not well-understood.
Zachary Burningham   +3 more
openaire   +4 more sources

Myoepithelial carcinoma with RB1 mutation: remarkable chemosensitivity to carcinoma of unknown origin therapy

open access: yesBMC Cancer, 2017
Background Myoepithelial carcinoma of soft tissue is a rare, malignant neoplasm that is morphologically and immunophenotypically similar to its counterpart in salivary gland.
Timothy M. Hoggard   +9 more
doaj   +1 more source

Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease.

open access: yesBlood, 1995
Multicentric Castleman's disease (MCD) is an atypical lymphoproliferative disorder defined using clinical and pathologic criteria. A characteristic of the MCD is a close association with Kaposi's sarcoma (KS), which occurs during the clinical course of ...
J. Soulier   +10 more
semanticscholar   +1 more source

C/EBPβ-1 promotes transformation and chemoresistance in Ewing sarcoma cells. [PDF]

open access: yes, 2017
CEBPB copy number gain in Ewing sarcoma was previously shown to be associated with worse clinical outcome compared to tumors with normal CEBPB copy number, although the mechanism was not characterized.
Abegglen, Lisa M   +12 more
core   +1 more source

Wnt inhibitory factor 1 (WIF1) methylation and its association with clinical prognosis in patients with chondrosarcoma

open access: yesScientific Reports, 2017
Chondrosarcoma (CS) is a rare cancer, but it is the second most common primary malignant bone tumor and highly resistant to conventional chemotherapy and radiotherapy.
Pei Liu   +4 more
doaj   +1 more source

Surgery in reference centers improves survival of sarcoma patients: a nationwide study

open access: yesAnnals of Oncology, 2019
Background NETSARC (netsarc.org) is a network of 26 sarcoma reference centers with specialized multidisciplinary tumor boards (MDTB) aiming to improve the outcome of sarcoma patients. Since 2010, presentation to an MDTB and expert pathological review are
J. Blay   +52 more
semanticscholar   +1 more source

Long-term renal function and hypertension in adult survivors of childhood sarcoma [PDF]

open access: yes, 2018
Aim: Little data is available on long-term renal impairment in survivors from childhood sarcoma. We investigated the prevalence of renal impairment and hypertension after very long-term follow-up in survivors who reached adulthood after treatment for ...
Andreoli, Gianmarco   +6 more
core   +1 more source

Delayed phlegmon with gallstone fragments masquerading as soft tissue sarcoma. [PDF]

open access: yes, 2016
Complications from lost gallstones after cholecystectomy are rare but varied from simple perihepatic abscess to empyema and expectoration of gallstones.
Bateni, Cyrus P   +3 more
core   +1 more source

The in ovo CAM-assay as a xenograft model for sarcoma [PDF]

open access: yes, 2013
Sarcoma is a very rare disease that is heterogeneous in nature, all hampering the development of new therapies. Sarcoma patients are ideal candidates for personalized medicine after stratification, explaining the current interest in developing a ...
Bracke, Marc   +6 more
core   +1 more source

Home - About - Disclaimer - Privacy